NEW YORK, June 12, 2017 /PRNewswire/ -- Missouri's sixth trial involving Johnson & Johnson's talcum powder products and their alleged association with ovarian cancer is now underway in the 22nd Circuit Court in St. Louis. During opening statements last Friday, attorneys for three women who died of the disease asserted that the healthcare products giant continued to market its talc-based powders, even as it was aware of mounting scientific evidence linking genital talc use to ovarian cancer. They also accused Johnson & Johnson of specifically marketing its Baby Powder and Shower-to-Shower franchises to African-American women, though some research suggested that they were more susceptible to the disease. (Case No. 1422-CC09326-01)
"Our Firm is representing numerous women and their families who have put forth similar allegations in their talcum powder lawsuits. We will be monitoring this trial closely, as it could provide insight into how other juries might rule in similar claims," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer that may be associated with Johnson & Johnson's talc-based powders.
Talcum Powder Verdicts
The talcum powder lawsuits currently at trial in Missouri were all filed on behalf of women who had allegedly incorporated Johnson & Johnson's Baby Powder and Shower-to-Shower products into their daily feminine hygiene routine for more than 25 years. All were allegedly found to have talc in their ovaries.
Johnson & Johnson is named a defendant in more than 3,000 talcum powder lawsuits nationwide, all of which were filed on behalf of women who allegedly developed ovarian cancer following the regular and repeated use of the company's talc-based powders for feminine hygiene purposes. More than 1,000 claims have been centralized in Missouri's 22nd Circuit Court, where four other talcum powder plaintiffs have already been awarded compensatory and punitive damages ranging from $55 million to $110 million. Johnson & Johnson has prevailed in just one trial.
Women who were diagnosed with ovarian cancer following the long-term use of talc-based powder for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/talcum-powder-lawsuit-news-jury-hears-opening-statements-in-missouris-sixth-ovarian-cancer-trial-bernstein-liebhard-llp-reports-300472374.html
SOURCE Bernstein Liebhard LLP